Medical Properties Trust stock hits 52-week low at 3.96 USD

Medical Properties Trust Inc. (MPT) has hit a 52-week low with its stock price at $3.96 USD, amid a difficult year for the company. The stock has declined by 11.78% over the past year, trading below its InvestingPro Fair Value, which indicates potential for future gains and places it among undervalued stocks to watch. MPT offers a dividend yield of 8.8%, which remains attractive despite the current challenges.

The price dip is attributed to ongoing market pressures and negative investor sentiment, highlighting the company's struggles in the current economic environment. Notably, MPT has consistently paid dividends for 22 straight years, reflecting its commitment to shareholders. To gain further insights, investors can utilize 10 additional ProTips and detailed analysis available on InvestingPro’s platform.

Despite the stock's decline, MPT reported strong second-quarter 2026 revenue of $259.28 million, surpassing analysts' expectations of $248.01 million. However, the company posted a small loss of $0.01 per share, missing the forecasted slight profit of $0.0047 per share. Normalized funds from operations remained stable at $0.15 per share, meeting expectations and showing an increase from $0.14 in the previous quarter.

Management cited robust growth in post-acute operators, with EBITDARM rising more than $70 million year-over-year. Additionally, MPT issued $2.4 billion in senior secured notes due in 2032 as part of a private placement and exchange transaction. This strategy allows for the redemption of senior notes maturing in 2026 and a partial redemption of those maturing in 2027, while also refinancing approximately $1.5 billion in unsecured notes due between 2027 and 2031.

These actions demonstrate MPT's ongoing efforts to manage its debt obligations and stabilize its financial performance.